ResMed Shares Up 26.6% Since SmarTrend's Buy Recommendation (RMD)
SmarTrend identified an Uptrend for ResMed (NYSE:RMD) on August 3rd, 2012 at $35.25. In approximately 6 months, ResMed has returned 26.62% as of today's recent price of $44.63.
In the past 52 weeks, ResMed share prices have been bracketed by a low of $28.67 and a high of $48.47 and are now at $44.63, 56% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 1.4%.
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of ResMed shares.
Log in and add ResMed (RMD) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Keywords: spotlights resmed